Bioidentical Hormone Therapy in Toronto

Woman lying awake in bed with a neutral expression, looking at the camera

Bioidentical hormone therapy is not a standard prescription. How hormones are prescribed — which formulations, routes, and combinations — depends on whether you are in perimenopause or menopause, your symptoms, and what you have already tried. Prescribing for perimenopause, where hormones are still fluctuating and often volatile, is fundamentally different from prescribing for menopause, where hormone production has largely stopped.

At White Lotus Clinic in Toronto, the process begins with understanding your specific hormonal picture — your symptoms and cycle history. From there, all appropriate options are reviewed with their benefits and risks so you can make an informed decision.

Care is led by Dr. Fiona McCulloch, ND, who has over 25 years of clinical experience in hormonal health, including prescribing bioidentical hormones across perimenopause and menopause. If you are considering bioidentical hormone therapy and want to understand your options, a consultation through our menopause and perimenopause program can help clarify what approach may be appropriate for your situation.

If You Have Been Told Your Symptoms Are Not Bad Enough

The most common patient we see for bioidentical hormone therapy is a woman in perimenopause or menopause who has already tried to get help. She has gone to her doctor and asked about hormones — and been told that she does not need them, that her symptoms are not bad enough, or that she is too young. She has read about the benefits of hormone therapy and wants someone to go through everything with her in detail, to explain all the pros and cons so she can make a decision that is right for her. Many patients describe wanting that conversation — the time to have their questions fully answered — and not being able to find it. Some have been prescribed antidepressants to manage hot flushes because their doctor was not comfortable prescribing hormones.

The second most common presentation is a woman who has already tried hormone replacement therapy in perimenopause — and it caused extreme bleeding, heavy bleeding, or other significant changes. She was then recommended to go on the birth control pill. What happened in many of these cases is a protocol-level issue: menopause-style prescribing was applied to a perimenopausal patient, and the volatile, still-active hormones of perimenopause responded unpredictably. Perimenopause is very different from menopause and requires specific treatment protocols. There are solutions for patients like this, using specific combinations of HRT designed for the hormonal ups and downs of perimenopause.

Whether you are seeking bioidentical hormone therapy for the first time or reconsidering it after a previous experience that did not go well, you are far from alone. Both of these situations are ones we see regularly, and both have clear clinical pathways forward.

Illustration of branching pathways representing different underlying hormonal patterns

Clinical Experience in Bioidentical Hormone Prescribing

White Lotus Clinic’s approach to bioidentical hormone therapy is grounded in over two decades of clinical experience with hormonal conditions — from PCOS and reproductive health through perimenopause and menopause.

  • Over 25 years of clinical experience with hormonal health conditions, including bioidentical hormone prescribing
  • Published author — 8 Steps to Reverse Your PCOS, a peer-reviewed resource in PCOS management
  • EndoANP board member — ongoing involvement in naturopathic endocrinology education
  • Ontario prescribing authority for bioidentical estrogen and progesterone
  • Dr. Fiona McCulloch completed a fellowship through the American Board of Naturopathic Endocrinology, with advanced training in endocrine assessment and hormonal treatment
  • Team model — both Dr. Fiona McCulloch, ND and Dr. Alex Triandall, ND (over 24 years of clinical experience) provide hormone consultations

Our approach begins with understanding each patient’s individual hormonal picture — symptoms, cycle patterns, health history, family history, and what she has already tried. We always explain the different hormones and then offer each available option, listing the benefits and risks for each. The patient participates in the decision with full information. Bioidentical hormones are prescribed when they are the right clinical choice for the individual — and the assessment helps clarify when they may not be. This is not a prescribing clinic that writes a standard protocol. It is a clinical practice where every treatment plan is built around the specific patient.

One clinical advantage that is directly relevant to bioidentical hormone therapy in perimenopause: because of our extensive background treating polycystic ovary syndrome, we have a lot of practical experience in managing heavy and irregular bleeding, variations of thickened endometrial lining, and progesterone prescribing across reproductive-age patients. These are the same clinical challenges that arise in perimenopause — and that many standard HRT protocols do not adequately address. A common reason that hormone therapy causes problems in perimenopause is that not enough suppression of the endometrial lining is done. This is something we can manage effectively because of our background in PCOS care.

What Are Bioidentical Hormones?

Bioidentical hormones are structurally identical to the hormones your body naturally produces — estradiol, progesterone, estriol, and testosterone. The term “bioidentical” refers to the molecular structure: these hormones interact with your body’s hormone receptors in the same way your own hormones do, because they are the same molecules.

A common misconception is that “bioidentical” means “compounded at a special pharmacy.” It does not. Standard pharmaceutical prescriptions like micronized progesterone (Prometrium) and estradiol patches are bioidentical — they are structurally identical to endogenous hormones, manufactured by pharmaceutical companies, and covered by most prescription drug insurance plans. Compounded formulations are also bioidentical. Even the conventional hormone therapy that we prescribe is bioidentical — it is simply produced by the pharmaceutical industry. The difference between pharmaceutical and compounded bioidentical hormones is in the manufacturing and availability, not in the molecular identity. This matters because it means bioidentical hormone therapy can be accessible and insurance-eligible — it does not have to mean expensive compounding pharmacy bills.

How Bioidentical Hormones Are Prescribed at Our Clinic

Transdermal Estrogen

Estradiol delivered through the skin via patches or creams. Transdermal estrogen does not pass through the liver — this is a pharmacological distinction that matters for safety, as the clotting risks identified in older studies were associated with oral estrogen’s liver metabolites. We can prescribe transdermal estrogen directly.

Vaginal Progesterone

We can prescribe vaginal progesterone directly. This route tends to work well for patients with heavy bleeding, or for those who want less of the sleep-inducing or neurological effects of progesterone. Vaginal progesterone delivers the hormone more locally, which can be advantageous when the primary goal is endometrial management rather than systemic effects.

Oral Progesterone

Oral micronized progesterone offers stronger sleep and neurological benefits — it is metabolized into allopregnanolone, a neurosteroid that promotes sleep through the GABA pathway. We refer for oral progesterone prescriptions when this route is the right clinical choice. Learn more about cyclic progesterone therapy and how progesterone is used across the menstrual cycle and menopausal transition.

Compounded Progesterone Cream

Compounding is required for progesterone cream because there is no commercially available progesterone cream on the market. When progesterone cream is the appropriate formulation, we work with compounding pharmacy partners in the Toronto area to fill the prescription.

Estriol

Estriol is used topically or vaginally for urogenital symptoms — vaginal dryness, urinary changes, and tissue health. It is a weaker estrogen than estradiol and is often used alongside other formulations. Read more about estriol for vaginal and urinary health during menopause.

Testosterone

We cannot prescribe testosterone. When testosterone is clinically indicated, we can refer to trusted prescribing partners. There are also many ways to support healthy testosterone levels outside of hormone supplementation — nutritional, lifestyle, and clinical strategies that can be part of the overall treatment plan.

Bioidentical Hormones in Perimenopause

In perimenopause, hormone production is still active — but it is unstable. Estrogen fluctuates, sometimes spiking to levels higher than pre-menopausal baseline, then dropping sharply. Progesterone is often the first hormone to decline significantly, and many perimenopausal women have a serious lack of progesterone while their estrogen is still volatile. This is why standard menopause protocols often fail when applied in perimenopause: stable hormone doses applied to an unstable hormonal environment can cause side effects like heavy bleeding, spotting, or worsening symptoms.

Our approach in perimenopause often begins with progesterone — particularly for patients with heavy periods, prolonged bleeding, or irregular cycles. Progesterone can help regulate the cycle and address the deficiency that drives many perimenopause symptoms. Estrogen may be added when there are signs of sustained low estrogen periods — to stabilize the fluctuations, essentially pushing back on the negative feedback mechanism that is driving the volatility. Whether we start with progesterone alone, a combination, or a specific protocol depends entirely on the individual. Patient preferences, family history, and clinical presentation always guide the decision.

In menopause, ovarian hormone production is minimal. A combination of estrogen and progesterone is more common at this stage — but again, this really depends on the patient. Some women specifically want the sleep benefits of progesterone, or the anti-inflammatory benefits. We always explain the different hormones and then offer each available option, listing benefits and risks for each, so the patient can make the decision that is right for her situation. Learn more about our menopause and perimenopause program.

Conditions Where Bioidentical Hormones May Be Considered

Is Bioidentical Hormone Therapy Safe?

In November 2025, the FDA removed black box warnings from hormone therapy products — a significant regulatory shift reflecting decades of updated research since the original Women’s Health Initiative (WHI) study. The WHI, which created widespread concern about hormone therapy, used oral estrogen combined with synthetic progestins in older women. Subsequent research has clarified that the risks associated with hormone therapy are route-dependent, formulation-dependent, and timing-dependent — not inherent to hormone therapy as a category.

Transdermal estrogen — delivered through the skin via patches or creams — does not undergo first-pass liver metabolism. The clotting risks identified in early HRT studies were associated with oral estrogen’s liver metabolites, a pathway that transdermal delivery avoids entirely. Micronized progesterone has a different safety profile from the synthetic progestins used in older studies: natural progesterone has not been shown to carry the same risks. These are route-of-administration and formulation distinctions — factual pharmacological differences, not marketing claims.

At White Lotus Clinic, bioidentical hormone therapy includes ongoing monitoring and regular reassessment. We prescribe at the lowest effective dose with gradual titration, guided by symptom response rather than numeric targets alone. All patients should continue following recommended breast screening guidelines for their age range.

For a detailed review of the evidence, read our article on bioidentical hormone therapy safety updates.

Insurance and Cost

Insurance Coverage
Insurance is not provided by OHIP but is typically included on most extended insurance plans.

Standard bioidentical hormone prescriptions — such as micronized progesterone and estradiol patches — are covered by most prescription drug insurance plans in Ontario, the same as any other prescribed medication. Bioidentical hormone therapy does not have to mean expensive compounding pharmacy bills. Many patients can use standard pharmaceutical prescriptions that are fully covered by their drug plan.

Compounded formulations are needed in specific situations — for example, progesterone cream, which has no commercially available equivalent and must be compounded. Insurance coverage for compounded prescriptions varies by plan. We work with multiple compounding pharmacies in the Toronto area.

Initial consultations are comprehensive — 90 minutes for the first visit. Virtual consultations are available for patients across Ontario. For current fee information, see our menopause and perimenopause program page.

If you are considering bioidentical hormone therapy and want to understand which approach may be right for your situation, a consultation through our menopause and perimenopause program is the place to start.

Frequently Asked Questions About Bioidentical Hormone Therapy

Are bioidentical hormones safe?

The safety profile of hormone therapy depends on the route of administration and the type of hormone used. In November 2025, the FDA removed black box warnings from hormone therapy products, reflecting updated evidence. The original safety concerns came from studies using oral estrogen combined with synthetic progestins. Transdermal estrogen — delivered through the skin — does not pass through the liver in the same way and has not been shown to carry the same clotting risk. Natural progesterone has a different safety profile from synthetic progestins. Regardless of formulation, all patients should follow recommended breast screening guidelines.

Read more about bioidentical hormone therapy safety updates.

Yes. Ontario naturopathic doctors with prescribing authority can prescribe bioidentical estrogen and progesterone. This is a scope-of-practice authorization regulated by the College of Naturopaths of Ontario (CONO) — it is not exclusive to any particular clinic. The practitioners at White Lotus Clinic have been prescribing bioidentical hormones for over two decades. For formulations outside naturopathic prescribing scope — such as oral progesterone or testosterone — we refer to trusted prescribing partners.

Bioidentical hormones are structurally identical to the hormones your body produces — the same molecular structure as your own estradiol, progesterone, and estriol. Synthetic hormones, such as medroxyprogesterone acetate, have a different molecular structure. An important distinction: “bioidentical” does not mean “compounded.” Standard pharmaceutical prescriptions like micronized progesterone (Prometrium) and estradiol patches are bioidentical — they are the same molecules, manufactured by pharmaceutical companies and covered by most drug plans. Compounded formulations are also bioidentical. The difference between pharmaceutical and compounded bioidentical hormones is in the manufacturing, not the molecular identity.

Standard bioidentical hormone prescriptions — micronized progesterone, estradiol patches — are covered by most prescription drug insurance plans in Ontario. These are pharmaceutical products, prescribed the same way as any other medication. Compounded formulations — such as progesterone cream, which has no commercially available equivalent — may or may not be covered, depending on the specific insurance plan. Many patients can use standard pharmaceutical prescriptions without needing compounding.

Many patients notice improvement within two to four weeks of starting bioidentical hormone therapy, with continued improvement over three months. Hormones have different types of effects — some are rapid, while others take longer. In particular, changes in tissue health, such as musculoskeletal complaints, can take longer to respond due to the nature of tissue healing. Individual responses vary, and the treatment plan is adjusted based on how each patient responds.

This is one of the most common presentations we see. In many cases, the issue was the protocol — not the concept of hormonal support. In perimenopause, the most common reason HRT causes problems is that not enough suppression of the endometrial lining is done. Standard menopause protocols applied to a perimenopausal patient — where hormones are still fluctuating and volatile — can cause heavy bleeding, spotting, or other side effects. The hormonal picture in perimenopause is very different from menopause and requires specific treatment protocols. Our clinical background in PCOS care gives us extensive experience with exactly this problem — managing heavy bleeding, irregular cycles, and endometrial lining variations with progesterone. A different protocol, individualized to perimenopause, is a different clinical approach.

Many family doctors are supportive of collaborative care. Our approach is designed to be complementary — not adversarial. You can share your assessment and treatment plan with your family doctor for coordinated care. Some patients find that their GP continues prescribing based on a protocol developed through the naturopathic assessment. We are happy to provide documentation that supports ongoing communication with your primary care provider.

Testosterone is outside our prescribing scope — we cannot prescribe it. If testosterone is clinically indicated based on the assessment, we can coordinate a referral to a trusted prescribing partner. That said, there are many ways to support healthy testosterone levels outside of hormone supplementation — nutritional, lifestyle, and clinical strategies that can be part of the overall treatment plan. Being transparent about what we can and cannot prescribe is part of how we build trust with our patients.

The first visit is a 90-minute comprehensive assessment. We review your full health history, current symptoms, menstrual cycle patterns, family history, past experiences with hormones or supplements, and your personal preferences and concerns. If appropriate, hormone and metabolic testing can help identify specific patterns — though testing is not always essential, as clinical assessment of symptom patterns and cycle history is also informative. From there, all available treatment options are presented with benefits and risks for each — progesterone alone, estrogen and progesterone in combination, compounded formulations, or non-hormonal approaches. You participate in deciding what is right for your situation. The first visit is a detailed clinical conversation that results in an individualized plan.

Learn more about our menopause and perimenopause program.

Bioidentical hormone therapy is based on clinical presentation — not age. Perimenopause can begin in the late 30s or early 40s, and women in their 70s may still benefit from specific formulations. The common experience of being told “you are too young for hormones” is one of the most frequent frustrations patients describe to us. The assessment evaluates the individual — your symptoms, hormone patterns, and health history — rather than applying an age-based rule. If your symptoms are affecting your quality of life and hormones are clinically appropriate, age alone is not a determining factor.

From First Visit to Ongoing Care

1

Comprehensive assessment (90 minutes)

We review your full health history, current symptoms, menstrual cycle patterns, family history, past experiences with hormones or supplements, and your personal preferences and concerns. This is a detailed clinical conversation, not a quick intake.

2

Hormone and metabolic testing, if appropriate

Testing can help identify specific hormonal patterns. It is not always essential — clinical assessment of symptom patterning and cycle history is also informative and often correlates well with the overall hormonal picture. Learn more about comprehensive hormone testing.

3

Treatment discussion

All available options are presented with benefits and risks for each. Progesterone alone, estrogen and progesterone, compounded formulations, non-hormonal approaches — you participate in choosing what is right for your situation.

4

Ongoing monitoring and adjustment

Regular follow-up to assess treatment response, adjust doses, and monitor safety markers. We prescribe to optimal dosing for your goals with gradual titration, guided by symptom response. Blood testing to determine hormone levels is also available where helpful — individual hormone levels can vary significantly and are a useful factor alongside symptoms in determining dose and delivery type.

Each protocol is individualized — because prescribing bioidentical hormones for perimenopause requires different clinical reasoning than prescribing for menopause, and every patient within each stage presents differently.

Many patients notice improvement within two to four weeks of starting bioidentical hormone therapy, with continued improvement over three months. Some changes — particularly tissue health and musculoskeletal improvements — take longer, due to the nature of how these tissues heal. These are general clinical observations, not guarantees, and individual responses vary.

When treatment is working well, patients often describe something beyond symptom improvement. They describe being able to do all the other things they want to do in life — whether that is exercise, activities, or work — things that hormonal symptoms had been displacing. Sometimes patients do not realize how well hormone therapy can work, or how much more quickly they can feel better, until they experience it.

Your Next Step

If you are considering bioidentical hormone therapy and want to understand what approach may be right for your situation, a consultation through our menopause and perimenopause program is the place to start. The first visit is a comprehensive, 90-minute assessment — we review your symptoms, health history, and goals before discussing any treatment options. You will understand your hormonal picture and what your options are.

Book a Consultation

Or call (416) 730-8218

You have done the research. The next step is an assessment with someone who can evaluate your specific situation — whether you are exploring bioidentical hormones for the first time or trying again after a previous experience. A detailed assessment can clarify your options.